Klebsiella pneumoniae K2 producer of pyogenic liver abscess associated with biliary communication.


Journal

Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410

Informations de publication

Date de publication:
30 09 2022
Historique:
received: 08 10 2021
accepted: 25 02 2022
entrez: 12 10 2022
pubmed: 13 10 2022
medline: 15 10 2022
Statut: epublish

Résumé

Hypervirulent strains of Klebsiella pneumoniae have gained clinical and epidemiological interest because of their capacity to cause severe and life-threatening infections. We report a case involving infection with a hypervirulent K. pneumoniae K2 strain that caused liver abscess in a young woman with type 1 diabetes in Mexico. The infection was found to be associated with biliary tract communication. The virulence factors and capsular serotypes were identified by polymerase chain reaction analysis. After guided drainage and directed antibiotic treatment, the infection resolved and the patient recovered. Colonization of the gastrointestinal tract by hypervirulent K. pneumoniae strains, together with the presence of comorbidity, such as diabetes are important factors that contribute to the development of liver abscess. The identification of virulent clones is important to understand the pathogenicity and improve control of infections in the patients.

Identifiants

pubmed: 36223631
doi: 10.3855/jidc.15914
doi:

Substances chimiques

Anti-Bacterial Agents 0
Virulence Factors 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1524-1529

Informations de copyright

Copyright (c) 2022 Daniel Aguilar-Zapata, Josefina Duran-Bedolla, Luis Esau Lopez-Jacome, Humberto Barrios-Camacho, Ulises Garza-Ramos, Rafael Valdez-Vazquez.

Déclaration de conflit d'intérêts

No Conflict of Interest is declared

Auteurs

Daniel Aguilar-Zapata (D)

Infectología y Epidemiología hospitalaria. Fundación Clínica Médica Sur, Ciudad de México. México.

Josefina Duran-Bedolla (J)

Instituto Nacional de Salud Pública (INSP), Centro de Investigación Sobre Enfermedades Infecciosas (CISEI), Laboratorio de Resistencia Bacteriana. Cuernavaca, Morelos, México.

Luis Esaú López-Jácome (LE)

Laboratorio de Infectología. Instituto Nacional de Rehabilitación, Ciudad de México. México.

Humberto Barrios-Camacho (H)

Instituto Nacional de Salud Pública (INSP), Centro de Investigación Sobre Enfermedades Infecciosas (CISEI), Laboratorio de Resistencia Bacteriana. Cuernavaca, Morelos, México.

Ulises Garza-Ramos (U)

Instituto Nacional de Salud Pública (INSP), Centro de Investigación Sobre Enfermedades Infecciosas (CISEI), Laboratorio de Resistencia Bacteriana. Cuernavaca, Morelos, México. ulises.garza@insp.mx.

Rafael Valdez-Vázquez (R)

Infectología y Epidemiología hospitalaria. Fundación Clínica Médica Sur, Ciudad de México. México.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH